James Robinson

James Robinson

Directeur Général chez UROVANT SCIENCES LTD.

Fortune : 344 720 $ au 31/08/2026

56 ans
Health Technology
Commercial Services
Consumer Services

Profil

James A. Robinson is President, Chief Executive Officer & Director at Urovant Sciences Ltd. since 2020.
He is President, Chief Executive Officer & Director at A2 Biotherapeutics, Inc. starting in 2024.
He serves as Director at Kenneth C.
Griffin Museum of Science & Industry, Chicago Horticultural Society, and Petauri Health LLC.
He is Independent Director at UroGen Pharma Ltd. and Eledon Pharmaceuticals, Inc. since 2023.
He is a Member of The Commercial Club of Chicago and Chicagonext (Bioscience Council).
Formerly, Mr. Robinson was Chief Executive Officer at Qlarity Imaging LLC.
He was President, Chief Executive Officer & Director at Urovant Sciences, Inc. from 2020 to 2023.
He was Director at Beacon Therapeutics (USA), Inc. from 2021 to 2022.
He was Director at World Business Chicago.
He was Independent Director at Neos Therapeutics, Inc. from 2019 to 2021.
He was Treasurer & Director at Pharmaceutical Research & Manufacturers of America in 2018.
He was Director & Founding Member at Innovation Development Institute, Inc. He was President & Chief Operating Officer at Alkermes, Inc. from 2018 to 2019.
He was Vice President-Hepatitis Sales & Managed Care at Schering-Plough Corp.
from 1992 to 2002.
He was President at Astellas Pharma US, Inc. from 2013 to 2016.
He was President at Astellas US LLC from 2016 to 2018.
He was President & Chief Operating Officer at Alkermes Plc from 2018 to 2019.
He was President & Chief Operating Officer at Paragon Biosciences LLC from 2019 to 2020.
Education includes an undergraduate degree from DePaul University conferred in 1992.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/08/2026 8 000 ( 0,02 % ) 344 720 $ 31/08/2026
31/03/2026 0 ( -.--% ) - $ 31/08/2026

Postes actifs de James Robinson

SociétésPosteDébut
UROVANT SCIENCES LTD. Directeur Général 23/03/2020
UROGEN PHARMA LTD. Directeur/Membre du Conseil 25/07/2023
ELEDON PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/10/2023
Directeur Général 01/04/2024
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Chicagonext
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de James Robinson

SociétésPosteFin
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de James Robinson

Formation de James Robinson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées23

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Chicagonext

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Services

Technology Services

  1. Bourse
  2. Insiders
  3. James Robinson
🔇